ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671660 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671660; 2) Community: the network communities that were significantly associated with the response to NSC 671660; 3) Molecule: the relationships between components within communities and NSC 671660; 4) MDR: the compounds that were significantly associated with the NSC 671660.

NSC Compound Enrichment Correlation
NSC 743220 N2-(4-fluorophenyl)-N3-(2-methoxyphenyl)-5-oxo-7-propyl-5H-[ 1,3]thiazolo[3,2-a]pyrimidine-2,3-dicarboxamide 0.0115521552688258 -0.062797317
NSC 745287 Null 0.0115521552688258 -0.22204996
NSC 715643 Null 0.0123744972338279 0.24679872
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.012374497233828 0.5462366
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.012374497233828 0.62334319
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.012374497233828 0.55199187
NSC 363812 Tetraplatin 0.012374497233828 0.44090565
NSC 380721 Eremantholide B 0.012374497233828 0.27951536
NSC 624771 5H-Benzocyclohepten-5-one, 4-(acetyloxy)-6,6-dibromo- 6,7,8,9-tetrahydro- 0.012374497233828 0.55300053
NSC 626539 Null 0.012374497233828 0.50960403
Total:111  Current:36    [First] [Prev] [Next] [Last]